Exelixis, Inc. · NASDAQ:EXEL
Farallon Capital Partners, L.P. reported a 0.40% stake in Exelixis, Inc. (Schedule 13D/A)
Event Jan 1, 2026 · Filed Jan 5, 2026
Farallon Capital Partners, L.P. reported a 0.40% stake in Exelixis, Inc., 1,189,334 shares, with active intent on Jan 1, 2026. Filed Jan 5, 2026 (Schedule 13D/A).
- Stake
- 0.40%
- Shares
- 1,189,334
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 31 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Farallon Capital Partners, L.P. | 0.40% | 1,189,334 |
| Farallon Capital Institutional Partners, L.P. | 0.50% | 1,397,425 |
| Farallon Capital Institutional Partners II, L.P. | 0.10% | 398,340 |
| Farallon Capital Institutional Partners III, L.P. | 0.10% | 201,793 |
| Four Crossings Institutional Partners V, L.P. | 0.10% | 263,099 |
| Farallon Capital Offshore Investors II, L.P. | 0.90% | 2,487,976 |
| Farallon Capital (AM) Investors, L.P. | 0.10% | 142,174 |
| Farallon Capital F5 Master I, L.P. | 0.20% | 476,750 |
| Farallon Healthcare Partners Master, L.P. | 3.40% | 9,152,609 |
| Farallon Partners, L.L.C. | 5.70% | 15,232,750 |
| Farallon Institutional (GP) V, L.L.C. | 0.10% | 263,099 |
| Farallon F5 (GP), L.L.C. | 0.20% | 476,750 |
| Farallon Healthcare Partners (GP), L.L.C. | 3.40% | 9,152,609 |
| Dapice Joshua J. | 5.90% | 15,709,500 |
| Dreyfuss, Philip D. | 5.90% | 15,709,500 |
| Dunn Hannah E. | 5.90% | 15,709,500 |
| Fried, Richard B | 0% | 0 |
| Gehani, Varun N. | 5.90% | 15,709,500 |
| Giauque, Nicolas | 5.90% | 15,709,500 |
| Husen, Avner A. | 5.90% | 15,709,500 |
| Kim, David T. | 5.90% | 15,709,500 |
| Linn, Michael G. | 5.90% | 15,709,500 |
| Luo Patrick (Cheng) | 5.90% | 15,709,500 |
| Patel, Rajiv A. | 0% | 0 |
| Roberts, Jr., Thomas G. | 5.90% | 15,709,500 |
| Saito Edric C. | 5.90% | 15,709,500 |
| Seybold, William | 0% | 0 |
| Short Daniel S. | 5.90% | 15,709,500 |
| Spokes, Andrew J. M. | 5.90% | 15,709,500 |
| Warren, John R. | 5.90% | 15,709,500 |
| Wehrly, Mark C. | 5.90% | 15,709,500 |
Source
Related
- Exelixis, Inc.
- Dapice Joshua J.
- Exelixis, Inc. shareholders
- Schedule 13D/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Form 4 · Beckerle Mary C · Aug 12, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Wyszomierski Jack L · Jun 3, 2026
- Form 4 · Eckhardt Sue Gail · Jun 3, 2026